PT Prodia Widyahusada TbkISX:PRDA +2.46%77 ROE % is 2.87% as of Mar. 2026, which is 77% below its 10-year median of 12.33. GuruFocus rates ISX:PRDA with a GF Score™ of 77/100 and a GF Value™ of Rp3,123.88 (Modestly Undervalued). The stock has 2 warning signs investors should review. Among 203 Medical Diagnostics & Research companies, PT Prodia Widyahusada Tbk ranks better than 74.38% on this metric.
ROE % measures the rate of return on the ownership interest (shareholder's equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' equity (also known as net assets or assets minus liabilities). ROE % shows how well a company uses investment funds to generate earnings growth. ROE %s between 15% and 20% are considered desirable.
The factors that affect a company's ROE % can be illustrated with the three-step DuPont Analysis:
Note:
The net income data used here is four times the quarterly (Mar. 2026) net income data. The Revenue data used here is four times the quarterly (Mar. 2026) revenue data. The same rule applies to Pre-Tax Income and Operating Income.
* In the five-step DuPont Analysis, Operating Income is only available for non-financial companies. Thus, for Insurance companies, we use EBIT as a substitution of Operating Income. For Banks, both Operating Income and EBIT is unavailable. Thus we combined Interest Burden and Operating Margin % into Pretax Margin %, and the DuPont Analysis is divided into four components instead.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
Net Income is used.
Because a company can increase its ROE % by having more financial leverage, it is important to watch the equity multiplier when investing in high ROE % companies. Like ROA %, ROE % is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.
Asset light businesses require very few assets to generate very high earnings. Their ROE %s can be extremely high.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Diagnostics & Research subindustry, PT Prodia Widyahusada Tbk's ROE %, along with its competitors' market caps and ROE % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
PT Prodia Widyahusada Tbk ROE % vs Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, PT Prodia Widyahusada Tbk's ROE % distribution charts can be found below:
* The bar in red indicates where PT Prodia Widyahusada Tbk's ROE % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual ROE %, the net income of the last fiscal year and the average total shareholder equity over the fiscal year are used. In calculating the quarterly data,
the net income data used here is four times the quarterly (Mar. 2026) net income data.
ROE % is displayed in the 30-year financial page.
PT Prodia Widyahusada Tbk (ISX:PRDA) has a ROE % of 2.87% as of Mar. 2026. Return on equity is the ratio of current-period net income to average two-period total equity. View historical data on PT Prodia Widyahusada Tbk and its competitors. This is 77% below median its historical median of 12.33. Over the past decade, PT Prodia Widyahusada Tbk's ROE % has ranged from 8.49 to 30.41. According to the industry distribution chart, PT Prodia Widyahusada Tbk ranks #52 out of 203 companies in the Medical Diagnostics & Research industry, placing it in the top 25.6%.
Is PT Prodia Widyahusada Tbk's ROE % too high?
PT Prodia Widyahusada Tbk's current ROE % of 2.87% is 77% below median its 10-year median of 12.33. Over the past 10 years, this metric has ranged from a low of 8.49 to a high of 30.41. Based on the distribution chart, PT Prodia Widyahusada Tbk ranks #52 out of 203 companies in the Medical Diagnostics & Research industry, which is above the industry midpoint. Overall, PT Prodia Widyahusada Tbk has a GF Score™ of 77/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does PT Prodia Widyahusada Tbk's ROE % compare to TMO and DHR?
According to the Medical Diagnostics & Research industry distribution chart, PT Prodia Widyahusada Tbk ranks #52 out of 203 companies for ROE %. This puts PT Prodia Widyahusada Tbk in the upper half of its industry. Historically, PT Prodia Widyahusada Tbk's own ROE % has ranged from 8.49 to 30.41 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROE % for a Medical Diagnostics & Research company?
A good ROE % depends on the Medical Diagnostics & Research industry context. However, ROE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROE % mean?
A high ROE % can signal that a stock is expensive relative to its fundamentals. Return on equity is the ratio of current-period net income to average two-period total equity. View historical data on PT Prodia Widyahusada Tbk and its competitors. PT Prodia Widyahusada Tbk's current ROE % is 2.87%, which is 77% below median its own 10-year median of 12.33. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PT Prodia Widyahusada Tbk stock overvalued right now?
Based on GuruFocus' analysis, PT Prodia Widyahusada Tbk (ISX:PRDA) is currently considered Modestly Undervalued. The stock's GF Value™ is Rp3,123.88, compared to a current price of Rp2,500.00 — trading 20% below its estimated fair value. The current ROE % is 2.87%, which is 77% below median its 10-year median of 12.33. PT Prodia Widyahusada Tbk's overall GF Score™ is 77/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROE % calculated?
ROE % is calculated from a company's financial statements. For PT Prodia Widyahusada Tbk (ISX:PRDA), the current ROE % is 2.87% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is PT Prodia Widyahusada Tbk (ISX:PRDA) Overvalued in 2026?
Based on GuruFocus' analysis, PT Prodia Widyahusada Tbk stock appears to be undervalued.
The current stock price of Rp2,500.00 is trading 20% below its estimated GF Value™ of Rp3,123.88.
GuruFocus considers PT Prodia Widyahusada Tbk to be Modestly Undervalued.
Key valuation signals for ISX:PRDA:
ROE %: 2.87% (77% below median its 10-year median of 12.33)
GF Value™: Rp3,123.88 vs. price of Rp2,500.00 (20% below fair value)
No single metric tells the full story. See the ISX:PRDA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
PT Prodia Widyahusada Tbk provides health care testing services. The company provides analytic and diagnostic services for the medical professionals. It is engaged in health laboratories by conducting business activities such as setting up clinics, health laboratories, management of hospitals, and health checkup services. Its operating segments are Central: Jakarta; Sumatera: Sumatera, Kepulauan Riau; Greater Jakarta: Jakarta, Bogor, Depok, Tangerang, Bekasi, Lampung, Pangkal Pinang; West Java; Central Java; East Java, Bali, Nusa Tenggara; Kalimantan Sulampua: Kalimantan, Sulawesi, Ambon, Papua.
77GF Score
Get the complete analysis for ISX:PRDA
ROE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ISX:PRDA has been successfully added to your 
